Harmony Biosciences

CNS diseases


HBM contact: Dr Ivo Staijen, Dr Emil Bujak

Company status: public

Harmony has the vision to develop and commercialize novel treatment options for people living with rare, neurological diseases. With a focus on disorders of sleep and wakefulness, Harmony Biosciences is currently working to advance the understanding of narcolepsy and provide information and resources to people who live with, and healthcare professionals who treat, this chronic, debilitating neurologic disorder.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171